NHU(SZ:002001)2022-11-11 07:57Financial Performance - In the first half of 2022, the company achieved operating revenue of 821,503.93 million yuan, an increase of 11.92% year-on-year [1] - Total profit was 262,396.23 million yuan, a decrease of 7.28% compared to the same period last year [1] - Net profit attributable to shareholders was 221,387.74 million yuan, down 8.78% year-on-year [1] Business Segment Performance - The nutrition segment saw a revenue increase of 4.81% year-on-year, driven by stable sales of methionine [2] - The flavor and fragrance segment experienced a revenue growth of 31.17% [2] - The new materials segment also grew, with a revenue increase of 32.06% [2] Project Progress - The methionine phase II project with a capacity of 250,000 tons/year is operating smoothly, with 100,000 tons currently in production [2] - The company is advancing its major projects, including a 15,000 tons/year methionine facility expected to be completed by June 2023 [2] - The new materials segment is progressing with a 7,000 tons/year PPS project currently in trial production [3] Market Insights - The supply shortage of natural gas in Europe is impacting vitamin market costs, but recovery in downstream demand may stabilize prices [2] - The company focuses on single vitamins, with no immediate plans to develop compound vitamins [3] - The solid methionine business is projected to have a capacity of 300,000 tons/year, with 150,000 tons currently in production [3] Future Outlook - The company aims to enhance its core competitiveness through continuous innovation and cost management [2] - Plans for the new materials segment include expanding production based on market demand [4] - The company is exploring opportunities in the biopharmaceutical sector, particularly in the fermentation field [4]